Statistics for aTyr Pharma (id:5627 LIFE)

Valuation metrics

Market cap

131.12M

Enterprise value

55.05M

Trailing P/E (ttm)

-3.17

Forward P/E

-2.53

PEG ratio

-2.53

Price/Sales (ttm)

222.99

Price/Book (mrq)

1.54

Enterprise Value/Revenue

93.62

Enterprise Value/EBITDA

-0.95

Overview

Shares outstanding

69.01M

Float

67.12M

Shares short

343.41K

% Held by insiders

0.03%

% Held by institutions

0.62%

Average volume (10 days)

584.74K

Average volume (90 days)

Price summary

52-Week low

1.14

52-Week high

3.80

52-Week change

59.40%

Beta

1.19

50-Day moving average

1.76

200-Day moving average

1.59

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

July 01th, 2019

Ex-dividend date

Last split factor

2:1

Last split date

July 01th, 2019

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

March 31th, 2024

Profitability

Profit margin

0.00%

Operating margin

-7,079.15%

Operational effectiveness

Return on assets

-29.37%

Return on equity

-55.61%

Income statement

Revenue (ttm)

0.01

Revenue per share (ttm)

0.01

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-58,078,000.00

Net income to common (ttm)

-53,929,000.00

Diluted EPS (ttm)

-0.88

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

84.50M

Total cash per share (mrq)

1.22

Total debt (mrq)

14.13M

Total Debt/Equity (mrq)

16.76

Current ratio (mrq)

606.50%

Book value per share (mrq)

1.24

Cash flow

Cash flow statement

-55,011,000.00

Levered free cash flow (LFCF)

-39,607,000.00